0 rating


Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.

Ruutiainen J, Viita AM, Hahl J et al.

Finnish Neuro Society, Masku, Finland.

 J Med Econ 2016;19:21–33.

Melinda Magyari’s review: This retrospective, cross-sectional study conducted in Finland confirms the finding in previous studies from other countries that multiple sclerosis (MS) is an expensive disease and that many of the costs are associated with disability. Finland is a country with a high incidence of MS, and the investigators aimed to estimate the economic and health-related quality of life (HRQoL) burden imposed by MS on people with the disease and on the rest of society. The study surveyed a population of patients who were registered with the Finnish Neuro Society, which is a national patient association in Finland.

Return to top


The Role of B Cells in Multiple Sclerosis: Experimental and Clinical Aspects
Til Menge, MD, Gerd Meyer zu Hörste, MD, and Bernd C Kieseier, MD
CML Multiple Sclerosis
Pharmacogenomics in Multiple Sclerosis
Manuel Comabella, MD and Xavier Montalban, MD
CML Multiple Sclerosis
The Role of MRI as a Predictive Marker for Disease Progression Measured by the Expanded Disability Status Scale
Antonia Ceccarelli, MD, Domenico Caputo, MD, and Marco Rovaris, MD
CML Multiple Sclerosis
Advances in Multiple Sclerosis Therapy: New Oral Disease-Modifying Agents
Andreas Lutterotti, MD and Thomas Berger, MD, MSc
CML Multiple Sclerosis
Optical Coherence Tomography as a Marker of Axonal Damage in Multiple Sclerosis
Shiv Saidha, MRCPI, Christopher Eckstein, MD, and John N Ratchford, MD
CML Multiple Sclerosis